Zosano Pharma Corp Pre-Tax Income
Zosano Pharma Corp reported Pre-Tax Income of -$33.41 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2022-05-13
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-03-31 was -$33.41M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-12-31 was -$6.97M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-09-30 was -$8.67M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-06-30 was -$6.14M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$29.93M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$33.37M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$37.59M.
- Zosano Pharma Corp income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$35.36M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$33.41M 10-Q · filed 2022-05-13 | -$40.38M derived: sum of 2 quarters · filed 2022-05-13 | -$49.05M derived: sum of 3 quarters · filed 2022-05-13 | -$55.19M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$15.64M derived: sum of 2 quarters · filed 2022-03-17 | -$21.78M derived: sum of 3 quarters · filed 2022-03-17 | -$29.93M 10-K · filed 2022-03-17 |
| 2021-09-30 | -$8.67M 10-Q · filed 2021-11-10 | -$14.81M derived: sum of 2 quarters · filed 2021-11-10 | -$22.95M 10-Q · filed 2021-11-10 | -$31.05M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$6.14M 10-Q · filed 2021-08-10 | -$14.29M 10-Q · filed 2021-08-10 | -$22.38M derived: sum of 3 quarters · filed 2022-05-13 | -$31.07M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$8.14M 10-Q · filed 2022-05-13 | -$16.24M derived: sum of 2 quarters · filed 2022-05-13 | -$24.93M derived: sum of 3 quarters · filed 2022-05-13 | -$32.82M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$16.79M derived: sum of 2 quarters · filed 2022-03-17 | -$24.68M derived: sum of 3 quarters · filed 2022-03-17 | -$33.37M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$8.69M 10-Q · filed 2021-11-10 | -$16.58M derived: sum of 2 quarters · filed 2021-11-10 | -$25.27M 10-Q · filed 2021-11-10 | -$34.21M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$7.89M 10-Q · filed 2021-08-10 | -$16.58M 10-Q · filed 2021-08-10 | -$25.52M derived: sum of 3 quarters · filed 2021-08-10 | -$35.39M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$8.69M 10-Q · filed 2021-05-12 | -$17.63M derived: sum of 2 quarters · filed 2021-05-12 | -$27.49M derived: sum of 3 quarters · filed 2021-05-12 | -$36.85M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$18.80M derived: sum of 2 quarters · filed 2021-03-11 | -$28.16M derived: sum of 3 quarters · filed 2021-03-11 | -$37.59M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$9.86M 10-Q · filed 2020-11-13 | -$19.22M derived: sum of 2 quarters · filed 2020-11-13 | -$28.65M 10-Q · filed 2020-11-13 | -$38.80M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$9.36M 10-Q · filed 2020-08-06 | -$18.79M 10-Q · filed 2020-08-06 | -$28.93M derived: sum of 3 quarters · filed 2020-08-06 | -$37.10M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$9.43M 10-Q · filed 2020-05-14 | -$19.57M derived: sum of 2 quarters · filed 2020-05-14 | -$27.74M derived: sum of 3 quarters · filed 2020-05-14 | -$36.58M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$10.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$18.32M derived: sum of 2 quarters · filed 2020-03-13 | -$27.15M derived: sum of 3 quarters · filed 2020-03-13 | -$35.36M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$8.17M 10-Q · filed 2019-11-14 | -$17.00M derived: sum of 2 quarters · filed 2019-11-14 | -$25.21M 10-Q · filed 2019-11-14 | -$32.70M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$8.84M 10-Q · filed 2019-08-14 | -$17.04M 10-Q · filed 2019-08-14 | -$24.53M derived: sum of 3 quarters · filed 2019-08-14 | -$32.40M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$8.21M 10-Q · filed 2019-05-14 | -$15.70M derived: sum of 2 quarters · filed 2019-05-14 | -$23.57M derived: sum of 3 quarters · filed 2019-05-14 | -$30.31M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$15.36M derived: sum of 2 quarters · filed 2019-03-25 | -$22.11M derived: sum of 3 quarters · filed 2019-03-25 | -$29.11M 10-K · filed 2019-03-25 |
| 2017-09-30 | -$7.87M 10-Q · filed 2018-11-15 | -$14.62M derived: sum of 2 quarters · filed 2018-11-15 | -$21.62M 10-Q · filed 2018-11-15 | -$29.36M derived: sum of 4 quarters · filed 2018-11-15 |
| 2017-06-30 | -$6.75M 10-Q · filed 2017-08-10 | -$13.74M 10-Q · filed 2017-08-10 | -$21.49M derived: sum of 3 quarters · filed 2018-05-15 | -$28.94M derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | -$7.00M 10-Q · filed 2018-05-15 | -$14.75M derived: sum of 2 quarters · filed 2018-05-15 | -$22.19M derived: sum of 3 quarters · filed 2018-05-15 | -$28.71M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$15.20M derived: sum of 2 quarters · filed 2018-03-12 | -$21.72M derived: sum of 3 quarters · filed 2018-03-12 | -$29.83M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$7.45M 10-Q · filed 2017-11-09 | -$13.97M derived: sum of 2 quarters · filed 2017-11-09 | -$22.08M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$6.52M 10-Q · filed 2017-08-10 | -$14.63M 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$8.12M 10-Q · filed 2017-05-09 |